Phase 3 studies showed BRENZAVVY significantly reduced hemoglobin A1c and fasting blood sugar after 24 weeks, either as a monotherapy, in combination with metformin, or as an add-on to standard-of-care treatment consisting of a variety of regimens, including metformin, sulfonylureas, insulin, DPP4 inhibitors, or combinations of these agents
First-class customer service means every service is with you in mind
In broad terms, Cigna commercial plans in 2026 cover Wegovy and Zepbound on Tier 3 with prior authorization
Never double up your dose of tirzepatide to make up for a missed dose, or take two doses within three days (72 hours) of each other
Sepsis emerged as the most common cause of AKI in this study, accounting for 55.2% of cases, followed by cardiorenal syndrome at 34.2% (Table S1 )
From a business perspective, Venezia said he doesnt begrudge IBX for making this decision or the pharmaceutical companies from making money